Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravenous streptomycin.

A G Driver1, J P Worden

  • 1Department of Medicine, East Carolina University School of Medicine, Greenville, NC 27858.

DICP : the Annals of Pharmacotherapy
|September 1, 1990
PubMed
Summary

Intravenous streptomycin offers a less painful alternative for treating tuberculosis (TB). This study explored its short-term use in four pulmonary TB patients, suggesting a viable alternative delivery method.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pericardial fluid adenosine in ischemic and valvular heart disease.

Chest·1995
Same author

Adenosine in bronchoalveolar lavage fluid in asthma.

The American review of respiratory disease·1993
Same author

Lovastatin-associated rhabdomyolysis.

Heart & lung : the journal of critical care·1991
Same author

Heimlich valve treatment of Pneumocystis carinii-associated pneumothorax.

Chest·1991
Same author

Bronchial challenge with adenosine causes the release of serum neutrophil chemotactic factor in asthma.

The American review of respiratory disease·1991
Same author

Expression of histamine H1 receptors on cultured histiocytic lymphoma cells.

Biochemical pharmacology·1989

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Pulmonary Medicine

Background:

  • Tuberculosis (TB) treatment often relies on streptomycin, a potent antibiotic.
  • Current streptomycin administration is exclusively intramuscular, causing significant patient discomfort.
  • Advancements in intravenous (IV) therapy necessitate re-evaluating alternative drug delivery routes.

Observation:

  • Four patients with active pulmonary tuberculosis were treated.
  • Short-term intravenous administration of streptomycin was employed.
  • Patient tolerance and efficacy were observed during the treatment period.

Findings:

  • Intravenous streptomycin was administered for a limited duration to patients with pulmonary tuberculosis.
  • The study observed the outcomes of this alternative administration route.
  • Preliminary data suggests feasibility of short-term IV streptomycin use.

Implications:

  • Re-evaluation of streptomycin's administration route is crucial for patient adherence.
  • Intravenous streptomycin may offer a more tolerable treatment option for tuberculosis.
  • Further research into long-term IV streptomycin therapy is warranted.

Related Experiment Videos